Screening For HPV Persistence And Cervical Cancer Risk
Links shared publicly online about this topic.
- 14total visits
Screening For HPV Persistence And Cervical Cancer Risk
View full resource at medicalnewstoday.com
Tags: Wart, STD, HPV, Cancer, Cervical Cancer, Cervical Cancer Prevention, Women's Health
Most Recently Shared on September 8, 2011 at 8:07 am By:
Screening For HPV Persistence And Cervical Cancer Risk http://mnt.to/3Zty #cervicalcancer #hpv
FDA Approves Hologic System for Cervical Cancer Screening | IVD Technology
ivdtechnology.com — “Hologic Inc. announced that FDA has approved its Cervista HTA (high throughput automation) system for use with the Company's previously approved Cervista human papillomavirus (HPV) HR test. The Company's HPV HR test utilizes Hologic's proprietary Invader technology to detect 14 high risk types of HPV that are associated with cervical cancer and precancerous lesions.” View full resource at ivdtechnology.com
Most Recently Shared on December 16, 2011 at 6:00 pm By:
FDA Approves Hologic System for Cervical Cancer Screening http://t.co/5zC0ilxo
Persistent HPV infection predicts cervical cancer risk - ONA
oncologynurseadvisor.com — “A large, long-term study indicates that women older than 30 years who test positive for human papillomavirus should be retested every 2 years to monitor cervical cancer risk.” View full resource at oncologynurseadvisor.com
Most Recently Shared on September 27, 2011 at 1:57 pm By:
Persistent HPV infection predicts cervical cancer risk http://ow.ly/6G7uh
Screening for HPV Persistence and Cervical Cancer Risk
jnci.oxfordjournals.org — “Screening for HPV Persistence and Cervical Cancer Risk” View full resource at jnci.oxfordjournals.org
Most Recently Shared on September 7, 2011 at 7:40 pm By:
http://t.co/F7ywU41 How frequently do women who test... http://t.co/ziOyzgT
Screening for HPV Persistence and Cervical Cancer Risk
jnci.oxfordjournals.org — “Screening for HPV Persistence and Cervical Cancer Risk” View full resource at jnci.oxfordjournals.org
Most Recently Shared on September 7, 2011 at 2:22 pm By:
From @JNCI_Now Screening for HPV Persistence and Cervical Cancer Risk http://t.co/iJ2IkvR #screening #cancer #HPV
Screening for HPV persistence and cervical cancer risk
eurekalert.org — “Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute.” View full resource at eurekalert.org
Most Recently Shared on September 7, 2011 at 1:45 am By:
Screening for HPV persistence and cervical cancer risk: ( Journal of the National Cancer Institute ) Women over ... http://t.co/q4wzdPx
Screening for HPV persistence and cervical cancer risk
medicalxpress.com — “Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute.” View full resource at medicalxpress.com
Most Recently Shared on September 6, 2011 at 8:48 pm By:
Screening for HPV persistence and cervical cancer risk http://t.co/RPjOH8X
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study : The Lancet Oncology
thelancet.com — “Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. By - ...” View full resource at thelancet.com
Most Recently Shared on August 23, 2011 at 3:40 pm By:
HPV testing for two high-risk strains could identify women at greatest risk of cervical cancer http://t.co/TIG3Bas
Despite Recommended Guidelines Annual Cervical Cancer Screening Persists - QualityPoint Technologies
qualitypointtech.net — “Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest. The results of the study are published online in the American Journal of Obstetrics & Gynecology (AJOG)...” View full resource at qualitypointtech.net
Most Recently Shared on August 21, 2011 at 11:00 am By:
Despite Recommended Guidelines Annual Cervical Cancer Screening Persists: Investigators from the Centers for Disea... http://t.co/byaRfH7
Despite Recommended Guidelines Annual Cervical Cancer Screening Persists
medicalnewstoday.com — “Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less” View full resource at medicalnewstoday.com
Most Recently Shared on August 21, 2011 at 7:07 am By:
Despite Recommended Guidelines Annual Cervical Cancer Screening Persists http://mnt.to/3Z4F #cervicalcancer #hpv
Annual Cervical Cancer Screening Persists, Despite Recommended Guidelines - Health News - redOrbit
redorbit.com — “Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest.” View full resource at redorbit.com
Most Recently Shared on August 19, 2011 at 6:44 am By:
Annual Cervical Cancer Screening Persists, Despite Recommended Guidelines: According to new CDC study in the Ame... http://t.co/wlQ180a
HPV test beats Pap for cervical cancer screening - seattlepi.com
seattlepi.com — “Two big studies suggest possible new ways to screen healthy people for cervical or prostate cancers, but a third disappointed those hoping for a way to detect early signs of deadly ovarian tumors. --"For women 30 and over, a test for the virus, HPV, is better than a Pap smear for predicting cervical cancer risk, and those who test negative on both can safely wait three years to be screened again. --"A single PSA blood test at ages 44 to 50 might help predict a man's risk of developing advanced p” View full resource at seattlepi.com
Most Recently Shared on May 19, 2011 at 3:16 am By:
HPV test beats Pap for cervical cancer screening: share: digg facebook twitter Two big studies suggest possible ... http://bit.ly/mbdJXc
Don't get complacent about cervical screening - News - Virtual Medical Centre
virtualmedicalcentre.com — “There is an emerging risk of women becoming complacent about cervical cancer screening, particularly women who have been vaccinated against human papillomavirus (HPV).” View full resource at virtualmedicalcentre.com
Most Recently Shared on February 19, 2011 at 1:19 pm By:
Don't get complacent about cervical screening http://dlvr.it/H1555 #Healthnews
Oncology Article | Papillomavirus Infections
mdlinx.com — “Risk of Cervical Precancer and Cancer in Women Aged 30 Years and Older With an HPV-Negative Low-Grade Squamous Intraepithelial Lesion Screening Result” View full resource at mdlinx.com
Most Recently Shared on January 11, 2011 at 3:08 pm By:
Risk of Cervical Precancer and Cancer in Women Aged 30 Years and Older With an HPV-Negative Low-Grade ... http://bit.ly/fNB0vx #oncology
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China : The Lancet Oncology
lancet.com — “Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. By - Fan...” View full resource at lancet.com
Most Recently Shared on November 15, 2010 at 10:23 pm By:
RT @HPVinformed: For you scientifically-savvy out there: #HPV testing in China from The Lancet Oncology journal http://bit.ly/djxh68
Advertisement

